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Abstract
Background: RNA polymerase III (pol III) type 3 promoters such as U6 or 7SK are commonly
used to express short-hairpin RNA (shRNA) effectors for RNA interference (RNAi). To extend
the use of RNAi for studies of development using the chicken as a model system, we have
developed a system for expressing shRNAs using the chicken 7SK (ch7SK) promoter.
Results: We identified and characterised the ch7SK promoter sequence upstream of the full-
length 7SK small nuclear RNA (snRNA) sequence in the chicken genome and used this to construct
vectors to express shRNAs targeting enhanced green fluorescent protein (EGFP). We transfected
chicken DF-1 cells with these constructs and found that anti-EGFP-shRNAs (shEGFP) expressed
from the ch7SK promoter could induce efficient knockdown of EGFP expression. We further
compared the efficiency of ch7SK-directed knockdown to that of chicken U6 (cU6) promoters and
found that the efficiency of the ch7SK promoter was not greater than, but comparable to the
efficiency of cU6 promoters.
Conclusion: In this study we have demonstrated that the ch7SK promoter can express shRNAs
capable of mediating efficient RNAi in a chicken cell line. However, our finding that RNAi driven by
the ch7SK promoter is not more efficient than cU6 promoters contrasts previous comparisons of
mammalian U6 and 7SK promoters. Since the ch7SK promoter is the first non-mammalian
vertebrate 7SK promoter to be characterised, this finding may be helpful in understanding the
divergence of pol III promoter activities between mammalian and non-mammalian vertebrates. This
aside, our results clearly indicate that the ch7SK promoter is an efficient alternative to U6-based
shRNA expression systems for inducing efficient RNAi activity in chicken cells.
Background
RNAi is a sequence-specific gene silencing mechanism [1]
initiated by 19–29 nucleotide (nt) duplexes known as
small-interfering RNAs (siRNAs) [2]. siRNAs are proc-
essed from long double-stranded RNA (dsRNA) mole-
cules by the ribonuclease III enzyme Dicer [3] and are
unwound and loaded as single-stranded RNAs into the
RNA induced silencing complex (RISC) [4]. RISC can then
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silence gene expression via cleavage of messenger RNA
(mRNA) transcripts that are complementary to the incor-
porated siRNA sequence [4]. RNAi-mediated silencing can
be adapted for specific gene targets in vertebrates via trans-
fection of siRNA duplexes [2] or DNA vectors which
express siRNAs as short-hairpin RNAs (shRNAs) [5]. shR-
NAs are transcribed from these vectors as 19–29 nt
inverted repeat sequences, separated by a 4–10 nt loop
sequence and fold spontaneously to form hairpin struc-
tures, which are cleaved by Dicer into active siRNAs [5,6].
Pol III type 3 promoters are most commonly used to
express shRNAs [6], as these promoters normally tran-
scribe endogenous small-nuclear RNAs (snRNAs) such as
U6 and 7SK. Termination of transcription by Pol III also
occurs at defined tracts of 4–5 thymidines (T4–5) [7],
which can be inserted downstream of shRNA coding
sequences to ensure direct termination. Unlike type 1 and
2 promoters, pol III type 3 promoters are located entirely
upstream of transcription start sites (+1) and feature char-
acteristic promoter elements including; a TATA box begin-
ning at around bp -20 (relative to +1), a Proximal
Sequence Element (PSE) centred around bp -50 and a Dis-
tal Sequence Element (DSE) beginning around bp -240
[7]. In the human U6 and 7SK (h7SK) promoters, the DSE
is comprised of at least one Octamer (OCT) motif [8,9]
and an SphI Post-octamer Homology (SPH) domain
[10,11]. The DSE of the human 7SK (h7SK) also, contains
an additional CACCC box enhancer located between the
OCT and SPH elements [12]. U6 promoters are the most
common type of promoter used for in vector-based
shRNA expression systems, however, more recent
approaches have preferred the use of 7SK promoters
[13,14].
Given the recent completion of the chicken genome
project [15], the adaptation and use of shRNA expression
systems for RNAi in the chicken will be important for
ensuing functional genomics studies. However, to date,
most shRNA expression systems used in chickens feature
mammalian pol III promoters. Although several chicken
U6 (cU6) promoters have now been characterised and
shown to drive efficient shRNA-mediated RNAi activity in
chickens [16,17], recent work has highlighted that 7SK
promoters in human (h7SK) and bovine (b7SK) can stim-
ulate more efficient shRNA expression and RNAi activity
than corresponding U6 promoters [13,14]. Given that
expression of the 7SK snRNA appears to be conserved
across non-mammalian and mammalian vertebrates [18]
we sought to investigate whether a chicken 7SK promoter
(ch7SK) would also confer greater levels of shRNA-medi-
ated RNAi activity than the recently-characterised cU6
promoters.
Results
Identifying the chicken 7SK promoter
Pol III type 3 promoters are characterised by the presence
of gene-external promoter elements 5' of the transcription
start site [7]. To identify the ch7SK promoter we used a
bioinformatics approach and scanned the chicken
genome for sequences with significant (80%) homology
to the chicken 7SK snRNA gene sequence (GenBank
Accession Number AJ890101). We then analysed the 5'
flanking regions of these sequences for the presence of pol
III promoter elements. The absence of sequences resem-
bling a TATA box within the 5' flanking regions of 7SK
snRNA BLAST hits on chromosomes 1, 2 and 4 (results
not show), indicated that these 5' flanking regions proba-
bly did not encode functional 7SK pol III promoters.
However, putative pol III promoter elements including a
TATA box with homology to that of both the h7SK and
b7SK promoters (Fig. 1), were present within the 5' flank-
ing region of the full-length, ch7SK snRNA sequence,
located on chicken chromosome 3 (Gga3, Contig
NW_060336.1). This analysis indicated that the chicken
genome contained only a single putative ch7SK promoter.
Using PCR we amplified a 783 bp region containing the
putative ch7SK promoter sequence, which was cloned
into pGEM®-T Easy. Sequencing of the cloned insert iden-
tified three clones; pch7SK-1 (783 bp), pch7SK-2 (782
bp) and pch7SK-3 (782 bp). Each of these clones showed
99% homology to the sequence immediately upstream of
the ch7SK snRNA transcription start site on chromosome
3 of the chicken genome. Alignment of the last 300 bp (5'
to 3') of each of these clone sequences against the h7SK
[19] and b7SK [14] promoter sequences, identified typical
pol III promoter elements including; a TATA box at bp -31
to -25, PSE at bp -67 to -46, and OCTmotifs at bp -222 to
-215 (OCT-1), bp -138 to -132 (OCT-2a) and bp -97 to -
90 (OCT-2b-not shown) and an SPH domain at bp -192
to -210 (Fig. 1). The PSE, OCT-1 and SPH elements also
displayed considerable homology to published consensus
sequences (Fig. 1) [20,21,11]. The presence of these ele-
ments within the cloned 5' flanking region of the ch7SK
snRNA gene sequence, suggested that this region probably
encoded a functional ch7SK promoter.
The ch7SK promoter expresses shRNAs
In order to validate its function, the putative ch7SK pro-
moter sequence was used to construct the shRNA expres-
sion vectors, pch7SK-shEGFP and pch7SK-MCS-shEGFP,
designed to transcribe shRNAs targeting EGFP (shEGFP)
(Supplementary Fig. 1). A third vector, pch7SK-shIrr,
designed to transcribe an irrelevant shRNA (shIrr) target-
ing an influenza virus nucleocapsid protein (NP) [22]
from the ch7SK promoter, was also constructed as a nega-
tive control (see Additional Files 1 and 2). The function of
the isolated ch7SK promoter sequence was verified byBMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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detection of shEGFP expression in chicken embryo fibrob-
last (DF-1) cells transfected with the pch7SK-shEGFP or
pch7SK-MCS-shEGFP constructs. RNA was extracted at 48
hours post-transfection and shEGFP expression was
detected using an RNase protection assay (RPA) (Fig. 2).
As a positive control for shEGFP detection, DF-1 cells were
also transfected with vectors expressing identical shEGFP
sequences from pre-validated mouse U6 (pmU6-shEGFP)
[23], chicken U6-1 (pcU6-1-shEGFP), chicken U6-4
(pcU6-4-shEGFP) or chicken U6-3 (pcU6-3-shEGFP) pol
III promoters [17].
A 19 nt band was detected in RNA samples from cells
transfected with both the pch7SK-shEGFP and pch7SK-
MCS-shEGFP constructs (Fig. 2). This band corresponded
with the expected size of protected shEGFP sequence as
well as specific bands detected in the positive control
mouse U6 (mU6) and cU6-shEGFP-transfected positive
control cells (Fig. 2). No shEGFP expression was detected
in RNA samples from the pch7SK-shIrr negative control,
or non-transfected cells (cells only) (Fig. 2). Detection of
miR-16 as a loading control in all transfected and control
RNA samples, confirmed the presence of total small RNAs
(Fig. 2). These results verified the predicted promoter
activity of the cloned ch7SK sequence and demonstrated
Detection of shEGFP expression from ch7SK-shEGFP  expression constructs in DF-1 cells Figure 2
Detection of shEGFP expression from ch7SK-shE-
GFP expression constructs in DF-1 cells. DF-1 cells 
were transfected with shEGFP expression constructs as indi-
cated above each lane. RNA samples were probed in solution 
with 32P-labelled shEGFP-specific LL91 RNA probe [14] and 
treated with RNAse A/T1. Protected shEGFP fragments 
were distinguished by comparison to RNA size markers 
(Decade™, Ambion).
Promoter element sequence alignment of chicken, bovine and human 7SK promoters Figure 1
Promoter element sequence alignment of chicken, bovine and human 7SK promoters. The enhancer (DSE) of the 
chicken 7SK promoter contains OCT-1 and SPH motifs but no CACCC box. The basal promoter region features a PSE and 
TATA box with homology to consensus. Matches to the defined consensus sequences indicated at the top of the OCT-1 [21], 
SPH [12], PSE [20] and TATA sequences are shown in upper case. Nucleotides conserved between chicken and either bovine 
or human 7SK promoter elements are underlined. Nucleotide positions indicate the location (5' → 3') of each element in the 
promoter relative to the transcription start site (+1). Each dash mark between the OCT-1 and CACCC box and PSE and 
TATA box represents one nucleotide. Nucleotide abbreviations in consensus sequences are according to the International 
Union of Biochemistry convention for GENBANK.BMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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that the ch7SK promoter could express shEGFP mole-
cules.
The ch7SK promoter directs shRNA-mediated RNAi 
knockdown
To verify that the shEGFP expressed by the ch7SK pro-
moter could direct RNAi-mediated knockdown of an
EGFP reporter gene, we conducted EGFP knockdown
assays by co-transfecting chicken DF-1 cells with the
pch7SK-shEGFP, pch7SK-MCS-shEGFP or positive con-
trol, pmU6-shEGFP and pEZ-b7SK-shEGFP [14] con-
structs, with an EGFP expression vector (pEGFP-N1) (Fig.
3). Given that co-transfection of reporter and shRNA
expression plasmids is considered to be 100% efficient for
validation of specific RNAi activity [24], we considered
any reduction in EGFP fluorescence intensity to reflect
RNAi-mediated EGFP knockdown. EGFP knockdown was
assessed for each co-transfection condition in duplicate
using fluorescence microscopy (Fig. 3a) and quantified
using flow cytometry by sampling the mean fluorescence
intensity (MFI) from triplicate co-transfections for each
condition (See Materials & Methods) (Fig. 3b).
In DF-1 cells co-transfected with pEGFP-N1 and either the
pch7SK-shEGFP or pch7SK-MCS-shEGFP constructs, the
EGFP MFI was significantly reduced to 45.19% (± 3.37%)
and 47.28% (± 3.14%) respectively (P < 0.001) (Fig. 3b
and see Additional file 3). These reductions were not
found to differ significantly from the EGFP MFI measured
in the positive control pmU6-shEGFP (42.8% ± 4.67%)
and pEZ-b7SK-shEGFP (45.27% ± 3.73%) co-transfected
cells (P > 0.05) (Fig. 3b). Given both the mU6 and b7SK
promoters are known to express functional shEGFP mole-
cules that direct specific EGFP knockdown in DF-1 cells
[17,23], this result indicated that the shEGFP molecules
expressed by the ch7SK promoter could direct efficient
knockdown (>50%) of EGFP in DF-1 cells.
Comparison of ch7SK and cU6 promoter induced EGFP 
knockdown
We further compared the efficiency of RNAi knockdown
mediated by the ch7SK promoter, to cU6 promoters; cU6-
1, cU6-3 and cU6-4, [16,17] by comparing the reduction
in EGFP MFI induced between the pcU6-1-shEGFP, pcU6-
3-shEGFP and pcU6-4-shEGFP vectors and the two
ch7SK-shEGFP constructs; pch7SK-shEGFP and pch7SK-
MCS-shEGFP (Fig. 3).
Fluorescence microscopy results indicated that the EGFP
knockdown induced by both of the ch7SK-shEGFP con-
structs was comparable to that induced by pcU6-4-shE-
GFP and pcU6-3-shEGFP, but greater than that conferred
by pcU6-1-shEGFP (Fig. 3a). However, statistical analyses
of MFI data (see Additional file 3) indicated no significant
difference in the reduction of EGFP MFI between the
pcU6-1-shEGFP (52.93% ± 6.25%), pch7SK-shEGFP
(45.19% ± 3.37%), pch7SK-MCS-shEGFP (47.28% ±
3.15%) or pcU6-3-shEGFP (39.78% ± 3.93%) transfec-
tion conditions (P > 0.05) (Fig. 3b). The pcU6-4-shEGFP
co-transfected cells showed the greatest reduction in EGFP
MFI to 29.05% (± 3.26%), which was significantly lower
than for the pch7SK-MCS-shEGFP and pcU6-1-shEGFP
co-transfected cells (P = 0.05), but not significantly differ-
ent to the MFI of either the pch7SK-shEGFP or pcU6-3-
shEGFP-co-transfected cells (P > 0.05) (Fig. 3b). Taken
together, these results indicated that neither of the ch7SK-
shEGFP constructs induced more efficient RNAi-knock-
down of EGFP than existing cU6-shEGFP constructs in
DF-1 cells.
Discussion
The chicken is an important livestock animal and a key
model for studies of vertebrate development and gene
function [25]. Thus the development of RNAi technolo-
gies adapted for use in chicken systems will be important
for further annotation of the chicken genome. Although
several recently characterised chicken U6 (cU6) promot-
ers have been used to develop effective chicken-specific
shRNA expression systems [16,17,26], 7SK promoters
have been shown to direct more efficient RNAi activity
than U6 promoters in mammals [13,14]. To investigate
whether this promoter relationship also exists in chickens
we have characterised the ch7SK promoter and compared
its ability to confer RNAi activity to that of existing cU6
promoters.
Although several 7SK pseudogenes exist in the chicken
genome [15] we characterised the ch7SK promoter
sequence upstream of the full-length chicken 7SK snRNA
sequence on chromosome 3. In the human, bovine and
mouse genomes only single functional 7SK promoters
have been identified upstream of 7SK snRNA coding
sequences [19,14,27]. Our finding that only the full-
length ch7SK snRNA sequence features an active upstream
promoter region is therefore consistent with the notion
that only a single functional 7SK promoter is present in
the chicken genome. The ch7SK promoter was also found
to contain typical pol III promoter elements; TATA, PSE,
OCT and SPH (Fig. 1) which show positional and
sequence similarities to those of the h7SK and b7SK pro-
moters (Fig. 1) [19,14]. Further, we noted that the ch7SK
locus was flanked by homologues of the glutathione S
transferase-A3 and intestinal cell kinase (MAK-related
kinase) genes which are also located 5' and 3' respectively
of the identified mammalian 7SK loci. This level of syn-
teny in the arrangement of the 7SK loci between chicken
and other mammalian species is also reflected in recent
comparative analyses of chromosome synteny blocks con-
served between chicken and mammalian genomes [15].
This apparent conservation in the arrangement of theBMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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ch7SK locus with respect to surrounding genes indicates
that the ch7SK promoter characterised in the present
study may be the only functional 7SK promoter in the
chicken genome.
Our results clearly demonstrated that the ch7SK promoter
was able to express functional shRNA molecules capable
of mediating greater than 50% RNAi-knockdown of the
target EGFP reporter gene. However, we found no evi-
dence that the ch7SK promoter could direct more efficient
shRNA-mediated RNAi knockdown compared to the cU6-
EGFP knockdown conferred by chicken 7SK and U6 promoters in DF-1 cells Figure 3
EGFP knockdown conferred by chicken 7SK and U6 promoters in DF-1 cells. (a) Fluorescence microscopy images of 
DF-1 cells transfected with pEGFP-N1 only, or co-transfected with pEGFP-N1 and various shEGFP expression plasmids as indi-
cated for each image. TA is transfection reagent-only control (no-plasmid DNA). Images presented are representative of 
results from three independent experiments at 60 hours post-transfection (Magnification 50×). (b) Flow cytometry results for 
EGFP knockdown assays in co-transfected DF-1 cells. shEGFP expression constructs co-transfected with pEGFP-N1 are indi-
cated on the x axis. EGFP knockdown was measured as a percent mean fluorescence intensity (MFI %), normalised to the aver-
age MFI of the negative control pch7SK-shIrr cells (100%). Error bars represent the standard error of the mean (SEM) 
calculated from at three independent experiments. Where no bars or error bars are visible the MFI and or SEM is less than 1%.BMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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1, cU6-3 and cU6-4 promoters. This interpretation was
based on a lack of significant difference in the level of
EGFP MFI between cells co-transfected with pch7SK-shE-
GFP and any of the cU6-shEGFP constructs, or between
cells co-transfected with pch7SK-MCS-shEGFP and pcU6-
1-shEGFP and pcU6-3-shEGFP. We cannot rule out how-
ever, that the ch7SK promoter may actually be less effi-
cient than the cU6-4 promoter, given that our MFI data
indicated the pcU6-4-shEGFP construct could direct a
more significant reduction in EGFP MFI than the pch7SK-
MCS-shEGFP construct (Fig. 3b). Our results also reflect
those of a recent study by Das et.al. [26], which compared
the efficiency of cU6 and mU6 promoters for expression
of a miRNA operon in DF-1 cells. The levels of luciferase
knockdown induced by the cU6 promoters of chromo-
somes 18 and 28 (equivalent to cU6-1 and cU6-4 in our
study respectively) are similar to those we have measured
for these promoters against EGFP (Fig. 3b). Kudo and
Sutou (2005) [16] and Wise et.al., (2007) [17] also report
that the cU6-4 promoter shows the highest efficiency of
the five cU6 promoters characterised so far; cU6-1, cU6-2,
cU6-3, cU6-4 [16] and cU6-1variant [17]. Consideration
of our results against these findings suggests therefore,
that the ch7SK promoter may indeed be less efficient than
the cU6-4 promoter. Given, however, that we could find
no significant difference in the level of EGFP knockdown
induced by shEGFP expressed from the ch7SK, cU6-1 and
cU6-3 promoters, indicates that in general, the efficiency
of the ch7SK promoter is comparable to that of these
other cU6 promoters.
Interestingly, our results contrast findings published by
Lambeth  et.al., (2006) [14] and Koper-Emde et. al.,
(2004) [13], who independently demonstrated that the
b7SK and h7SK promoters confer more efficient shRNA
expression and RNAi activity than bovine and human U6
promoters, respectively. Despite close alignment of the
ch7SK, h7SK and b7SK promoter elements, we noted
some distinct differences within the DSE or enhancer
region of the ch7SK promoter, which affect the structural
organisation of the ch7SK promoter in relation to its
mammalian homologues (Fig. 1). Given the structure and
sequence of promoter elements within the DSE can influ-
ence maximal transcription efficiency in U6 and 7SK pro-
moters [8,28,29], the variable structure of the ch7SK DSE
may have an inherent impact upon its efficiency relative
to U6 promoters.
Unlike the b7SK and h7SK promoters, the DSE of the
ch7SK promoter does not contain a CACCC box (Fig. 1),
which appears to be a distinct feature of 7SK promoters
and is reported to serve an important role in enhancing
the transcriptional activity of the h7SK promoter [12]. It is
possible that the absence of a CACCC box in the ch7SK
promoter may affect its overall efficiency by reducing
enhancer activity in the ch7SK DSE to a level more similar
to that seen in U6 promoters. This could explain why we
observed comparable levels of EGFP knockdown induced
between the ch7SK and cU6 promoters. Moreover, the
absence of the CACCC box from the enhancer may further
indicate that the enhancer mechanism in the ch7SK pro-
moter may be more similar to that of U6 promoters than
other mammalian 7SK promoters.
A second feature of the ch7SK enhancer, distinct from
mammalian 7SK promoters is the presence of a C/A sub-
stitution at position 1 (bp -222) of the ch7SK OCT-1
motif (Fig. 1). Previous work has shown that mutation of
the OCT-1 motif in the h7SK promoter has the strongest
impact on transcriptional efficiency [29], so it is possible
that this substitution may affect the activity of the ch7SK
enhancer. However, an OCT-1 sequence identical to that
of the ch7SK promoter is present in the enhancer of the
RNA polymerase II (pol II) promoter of the chicken U4B
(cU4B) snRNA [30] (see Additional files 4 and 5), which
shows full affinity for the Octamer transcription factor
(Oct-1) [31]. Therefore, it is unlikely that the ch7SK OCT-
1 motif would affect promoter efficiency through a
reduced ability to bind Oct-1. Optimal enhancer activity
in the cU4B promoter however, is also dependent upon
the presence of a downstream SPH domain adjacent to
OCT-1 [31]. Interestingly, the position of the ch7SK SPH
domain 4 bp downstream of OCT-1 corresponds closely
to that of the cU4B promoter and shows striking homol-
ogy (84%) to the cU4B SPH sequence (see Additional files
4 and 5) [30]. Given this level of structural identity, it is
pertinent to suggest that the enhancer mechanism operat-
ing in the ch7SK promoter may be analogous to that of the
cU4B promoter and require adjacent OCT-1 and SPH
domains.
Co-dependence of OCT and SPH motifs in pol III
enhancer mechanisms is common to other non-mamma-
lian vertebrate pol III promoters including the Xenopus
laevis tRNAsec promoter [32]. Similarly, human U6 pro-
moters also appear to rely upon the presence of both OCT
and SPH elements for efficient enhancer activity [10]. This
type of enhancer mechanism contrasts what is known
about the function of the h7SK enhancer, where optimal
transcription efficiency is not dependent upon the pres-
ence of an SPH domain [29]. Therefore, based on the
structural features of the ch7SK enhancer, we propose that
ch7SK enhancer mechanism may be less divergent from
pol II and pol III promoters such as U4B and U6, than
from other mammalian 7SK promoters.
Since ours is the first study to characterise the a non-mam-
malian vertebrate 7SK promoter, further characterisation
and cross-species analysis of other vertebrate 7SK promot-
ers would be necessary to evaluate this notion of divergentBMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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7SK enhancer mechanisms. Whilst this type of investiga-
tion was beyond the scope of our study, it would go fur-
ther to more strongly define promoter characteristics
which govern the efficiency of 7SK promoters. This
knowledge would be of substantial benefit to the develop-
ment of more efficient shRNA expression systems for
cross-species RNAi applications.
Conclusion
In this study we have identified and isolated a functional
chicken homologue of the 7SK snRNA promoter and
demonstrated its ability to confer efficient shRNA expres-
sion and RNAi-knockdown of a reporter gene in a chicken
cell line. We further found that the efficiency of the ch7SK
promoter was similar to that of existing cU6 promoters,
which contrasts previous comparisons of mammalian U6
and 7SK promoters. The ch7SK promoter is the first non-
mammalian vertebrate 7SK promoter to be characterised,
so this finding may reflect inherent differences in the
divergence of pol III promoter activities between mamma-
lian and non-mammalian vertebrates. This aside, our
results clearly indicate that the ch7SK promoter is an effi-
cient alternative to U6-based shRNA expression systems
for inducing efficient RNAi activity in chicken cells. This
and the characterisation of other chicken-specific promot-
ers for RNAi applications will be of particular benefit to
furthering functional genomic analysis of the chicken
genome and in developmental studies which utilise the
chicken as a model system.
Methods
Isolation of the ch7SK promoter from chicken genomic 
DNA
The ch7SK promoter sequence was amplified from
chicken genomic DNA extracted from chicken embryo
fibroblast (DF-1) cells (ATCC, CRL-12203) (Wizard®
Genomic DNA purification kit, Promega), using the prim-
ers: forward (TD245): 5'-GTCCAGCCATCCACCTCCCAC-
CAATACTTC-3' and reverse (TD237): 5'-AAAGCTACGAG
CTGCCCCAA-3'. Gradient PCR was conducted using; 9.5
ng of genomic DNA, 100 ng of each primer (TD245 &
TD237), 2 mM MgCl2  (Qiagen), 250 µM dNTPs
(Promega), 1 × PCR buffer (Qiagen) and 1 unit of Thermus
acquaticus (Taq) polymerase (Promega), in a Mastercycler
EP Gradient S thermocycler (Eppendorf AG). Cycle condi-
tions were: 94°C – 5 minutes, 35 cycles of; 94°C – 1
minute, 69.4°C – 45 sec and 72°C – 1 minute, with a 5
minute final extension at 72°C.
A single PCR product of approximately 780 bp was ampli-
fied, purified using the Wizard SV PCR and Gel cleanup
kit (Promega) and cloned using the pGEM®-T Easy vector
cloning system (Promega). Ligations were transformed
into TOP10F' Escherichia coli (E. coli) cells (Invitrogen)
and plasmid DNA isolated from bacterial clones
(QIAprep® Spin Miniprep Kit, Qiagen) was sequenced
(Micromon DNA sequencing facility, Monash Univer-
sity). Sequences were compared to public sequence data-
bases using the mega-Basic Local Alignment Search Tool
(mega-BLAST) [33]. The sequences of three clones con-
taining the putative ch7SK promoter sequence; pch7SK-1
(783 bp), pch7SK-2 (782 bp) and pch7SK-3 (782 bp),
were deposited into Genbank under the accession num-
bers, EF488955, EF488956 and EF488957 respectively.
Construction of ch7SK-shRNA expression vectors
The pch7SK-shEGFP and pch7SK-shIrr expression vectors
were constructed using the one-step PCR approach as
described previously [17] (see Additional files 1 and 2).
The primers used were; forward primer TD269 (5'-GAG-
GCTCAGTGTCACGCAGA-3') and reverse primer TD267
(5'-
CTCGAGTTCCAAAAAAGCTGACCCTGAAGTTCATCTCT
CTTGAAGATGAACTTCAGGGTCAGCAAAGCTAC-
GAGCTGCCCCAA-3') (shEGFP) and TD268 (5'-
CTCGAGTTCCAAAAAAGGATCTTATTTCTTCGGAGTCTC
TTGAACTCCGAAGAAATAAGATCCAAAGCTACGAGCT-
GCCCCAA-3') (shIrr). pch7SK-shEGFP was amplified
using pch7SK-3 template and pch7SK-shIrr was amplified
using pch7SK-1 template.
The pch7SK-MCS-shEGFP vector was constructed from
the pch7SK-MCS base-vector by ligation of complimen-
tary annealed oligonucleotides (oligos) LL29 and LL30 as
described previously [14] (see Additional files 1 and 2).
The pch7SK-MCS base vector was constructed from
pUC57 by ligating a 315 bp synthetic copy of the ch7SK
promoter sequence between the EcoRI and HindIII sites
(Celtek Genes). The ch7SK promoter sequence was altered
between bp -5 to +11 to include a 3' multi-cloning site
(MCS) comprising overlapping KpnI, XhoI and EcoRI sites
(see Additional files 1 and 2). All ligations were incubated
at 4°C for 48 hours and transformed into TOP10F' E. coli.
Sequence management and bioinformatics
Chicken genome sequence information was accessed
through the National Centre for Biotechnology Informa-
tion (NCBI) database [34] and viewed using the NCBI
Map Viewer, Gallus gallus (chicken). Sequence alignments
were performed using ClustalW [35] and Clone Manager
7 software (SciEd Central).
Cell culture and transfection
Chicken DF-1 cells were maintained in 5% CO2 at 37°C
in growth media as described previously [17] and har-
vested using 0.25% (w/v) trypsin-ethylenediamine-
tetraacetic acid (EDTA). Transfection of plasmid DNA for
EGFP silencing assays was conducted in DF-1 cells grown
to 80–90% confluence, in 8-well chamber slides (Nunc)
for fluorescence microscopy or 24 well culture platesBMC Biotechnology 2007, 7:79 http://www.biomedcentral.com/1472-6750/7/79
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(Nunc) for flow cytometry. Cells were transfected with
500 ng or 1 µg of each plasmid, per well, for chamber
slides or 24-well plates, respectively, using Lipo-
fectamine™2000 transfection reagent (Invitrogen). For
RNA extractions, DF-1 cells were grown in 25 cm2 culture
flasks (Corning) and transfected using 12.5 µg of plasmid
and 25 µl of Lipofectamine™2000.
Detection of shEGFP expression by RNase protection 
assay
RNA samples enriched for small RNAs (mirVana miRNA
isolation kit, Ambion) were purified from DF-1 cells 48
hours post-transfection of shEGFP expression plasmids.
An RNAse protection assay (RPA) was conducted to detect
expression of shEGFP (mirVana Probe & Marker Kit,
Ambion) using the RNA probe LL91 as described previ-
ously [14,17]. Expression of the miR-16 effector sequence
was detected using the mir-16 RNA probe provided with
the mirVana Probe & Marker Kit, (Ambion). Duplicate
RNA samples were prepared and probed separately for
Probes were hybridised in-solution to duplicate RNA sam-
ples for detection of shEGFP and mir-16 expression. Mir-
16 and shEGFP-probed RNA samples were RNase A/T1
treated according to the manufacturer's protocol
(Ambion) and run on separate 15% polyacrylamide (8 M
urea) gels. Gels were exposed to Medical X-ray film over 5
days at -80°C. Autoradiographs were developed using an
FPM-100A X-ray processor (FUJIFILM).
EGFP knockdown assays
EGFP expression was analysed at 60 hours post-transfec-
tion. Fluorescence microscopy was performed on dupli-
cate co-transfections using a Leica DM LB Fluorescence
Microscope (Leica Microsystems, Germany). Images were
captured at 50× magnification using a Leica DC300F col-
our digital camera (Leica Microsystems, Germany) using
Photoshop 7.0 imaging software (Adobe®). For flow
cytometry, the EGFP fluorescence intensity was quantified
as a mean fluorescence intensity (MFI) value for each co-
transfection condition sampled in triplicate. Cells were
harvested using 0.25% trypsin-EDTA, pelleted at 2000
rpm for 5 minutes, washed sequentially in cold phosphate
buffered saline-A (PBSA) (Oxoid) and FACS-solution
(PBSA + 1% FCS) and re-suspended in FACS-solution for
sampling. Sampling and data acquisition was conducted
using a FACScalibur (Becton Dickinson) fluorescence acti-
vated cell sorter and CELLQuest software (Becton Dickin-
son). The reduction in EGFP MFI for each co-transfection
was calculated by normalising the average MFI from trip-
licate sampling, as a percentage of the MFI of the negative
control shIrr/pEGFP-N1 co-transfected cells (100% ±
4.53% (SEM)) (Fig. 3b).
Statistics
Normalised MFI data from three independent co-transfec-
tion experiments was analysed statistically by One-way
Analysis Of Variance (ANOVA) and Tukey's multiple
comparisons tests (Prism, GraphPad Software) (see Addi-
tional file 3). Significant difference in EGFP knockdown
was accepted where P < 0.05.
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